Wall Street analysts have revised the price target for Priority Technology Holdings (PRTH) to $11, while maintaining a steady fair value estimate, as the firm navigates a mixed earnings quarter and ongoing ownership developments.
Bill and Hillary Clinton have agreed to appear before the House Oversight Committee as part of its investigation into the Jeffrey Epstein case, a spokesperson confirmed, signaling a major development in the long-running inquiry.
Simon Property Group reported robust fourth-quarter and full-year 2025 results, highlighted by record funds from operations, $2 billion in strategic acquisitions, and a significant return of capital to shareholders. The retail REIT giant provided optimistic 2026 guidance, banking on a strong development pipeline and resilient tenant demand despite acknowledging tariff-related headwinds.
Under new CEO Michael Leiters, Porsche is reportedly considering the cancellation of its long-awaited electric 718 Cayman and Boxster models amid development challenges and strategic cost-cutting measures.
Capital Southwest Corporation (NASDAQ: CSWC) reported strong fourth-quarter revenue growth of 18.2%, surpassing Wall Street expectations. However, the business development company's GAAP earnings per share came in modestly below analyst consensus estimates.
The U.S. Space Development Agency's major contract award to Rocket Lab marks a pivotal expansion for the launch provider into the lucrative defense sector, with analysts forecasting accelerated revenue growth and a path to profitability.
Rigetti Computing secures a significant order to deliver a 108-qubit quantum system to India's Centre for Development of Advanced Computing, marking a key commercial milestone and international expansion for the company amidst volatile stock performance.
Business Facilities magazine has named North Carolina its 'State of the Year' for business climate and economic development, the state's third such win in six years, following a surge of multi-billion dollar investments from tech and manufacturing giants.
Porsche's highly anticipated electric 718 Cayman and Boxster face potential cancellation under new leadership, with insiders citing cost overruns and development hurdles amid shifting market dynamics.
OpenAI has released a mobile application for its Codex AI coding assistant, aiming to close the gap with competitors like Anthropic in the lucrative and fast-growing market for AI-powered software development tools.
OpenAI has released a mobile application for its Codex AI coding assistant, aiming to capture market share in the competitive and fast-growing field of AI-powered software development. The move signals a strategic push to make its tools more accessible and user-friendly.
Porsche's planned all-electric 718 Boxster and Cayman models face potential cancellation as the automaker grapples with development challenges and a shifting financial landscape, according to insiders.
French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
Under new CEO Michael Leiters, Porsche is reportedly considering axing its planned all-electric 718 Boxster and Cayman line. The potential move, driven by development hurdles and soaring costs, signals a strategic recalibration as the automaker grapples with a sales slowdown in China and the financial weight of revising its EV roadmap.
Forrestania Resources moves to 100% ownership of the historic Mt Palmer gold project in Western Australia through a share-based acquisition, aiming to fast-track development and feed its Lake Johnston processing facility.
Barclays initiates coverage with an Overweight rating and $20 price target on Altimmune, citing strong fundamentals and pipeline potential. The biotech firm prepares to channel recent offering proceeds toward its pivotal Phase 3 development for metabolic liver disease treatment pemvidutide.
BofA Securities has trimmed its price target for Uber Technologies, citing near-term uncertainties in the autonomous vehicle sector, even as the company launches a new internal data initiative aimed at accelerating AV development.
Edwards Lifesciences (NYSE: EW) has terminated its planned takeover of JenaValve, opting instead to reinvest capital into its internal transcatheter aortic (TAVR) and mitral valve development programs. The strategic pivot underscores a renewed focus on organic growth in its core structural heart business.
During UK Foreign Secretary Yvette Cooper's visit to Addis Ababa, British investor Gridworks signed landmark agreements to develop two major transmission projects. The deals, part of a broader UK strategy linking economic development with migration management, mark Ethiopia's first public-private partnerships in its power transmission sector.
